USC scientists ID protein that regulates cellular trafficking, potential for anti-cancer therapy

By Alison Trinidad

Chengyu Liang, MD, PhD, was the principal investigator on a new study that discovered two intracellular processes that could lead to novel therapeutics for cancer treatment. Chengyu Liang, MD, PhD, was the principal investigator on a new study that discovered two intracellular processes that could lead to novel therapeutics for cancer treatment.

Molecular microbiologists at the Keck School of Medicine of USC have uncovered intricate regulatory mechanisms within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases. Their findings, which have long-standing significance in the basic understanding of cell biology, appear in the journal Nature Cell Biology.

“Our research reveals a new regulatory mechanism that coordinates two distinct intracellular processes that are critical to cellular homeostasis and disease development,” said Chengyu Liang, MD, PhD, assistant professor of molecular microbiology and immunology at the Keck School and principal investigator of the study. Read More »

October 18th, 2013|Announcements|

BREAST CANCER GENE DECODED IN FILM

 

(Photo/Leslie Ridgeway) (Photo/Leslie Ridgeway)

Stephen B. Gruber (far right), MD, MPH, director of the USC Norris Comprehensive Cancer Center, discusses his thoughts about the discovery of the BRCA1 breast cancer gene at Read More »

October 17th, 2013|Announcements|

KICKIN’ CANCER

(Photo/Courtesy USC Norris Kickin’ Cancer Team) (Photo/Courtesy USC Norris Kickin’ Cancer Team)

A team of USC Norris Comprehensive Cancer staff members took to the streets to support the early detection and prevention of women’s cancers. The 12th annual Kickin’ Cancer 5K run/walk and family expo, held on Sept. 29, was held by the Lynne Cohen Foundation for Ovarian Cancer Research. The USC Norris team raised a total of $5,535 for preventive care, collaboration and education for ovarian and breast cancer. Read More »

October 11th, 2013|Announcements|

Willliam Gorenstein appointed new chief financial officer of Keck Medicine of USC

By Tania Chatila

William Gorenstein William Gorenstein

William M. Gorenstein, CPA, has been appointed chief financial officer for Keck Medicine of USC, leading financial operations for the entire medical enterprise, and playing a key role in managing the system’s financial accountabilities, sustainability and long-term fiscal goals.

“This is a new role for our Keck Medicine senior team and one that is crucial to our journey forward, especially as we expand our system’s reach through ongoing investments and strategic partnerships,” said Tom Jackiewicz, MPH, senior vice president and CEO for USC Health, to whom Gorenstein reports. Read More »

September 27th, 2013|Announcements|

Board of Overseers member lends support to USC Norris 40th anniversary celebration

By Leslie Ridgeway

Keck School Board of Overseers member Deborah Lanni is a presenting sponsor at the 40th year celebration gala for the USC Norris Comprehensive Cancer Center. Keck School Board of Overseers member Deborah Lanni is a presenting sponsor at the 40th year celebration gala for the USC Norris Comprehensive Cancer Center.

Philanthropist and Pasadena resident Deborah Lanni has pledged $250,000 as a presenting sponsor to support the USC Norris Comprehensive Cancer Center, which is celebrating its 40th year with a gala celebration this fall.

The event, titled “40 Years of Progress — Discovering New Cures” will take place Friday, Oct. 11, from 6:30 to 10 p.m. at the Westin Bonaventure hotel. Award-winning comedian and actor Martin Short will emcee, and there will be special musical entertainment.

The goal of the event is to raise more than $1 million for cancer research at USC Norris while looking back on breakthroughs and successes and looking forward to the future of cancer research. Read More »

September 23rd, 2013|Announcements|